Profound Medical Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PROF research report →
About the company
Profound Medical Corp. , through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief.
- CEO
- Arun Swarup Menawat
- IPO
- 2019
- Employees
- 142
- HQ
- Mississauga, ON, CA
Price Chart
- Market Cap
- $206.07M
- P/E
- -5.54
- P/S
- 11.07
- P/B
- 4.19
- EV/EBITDA
- -4.52
- Div Yield
- 0.00%
- Gross Margin
- 71.04%
- Op Margin
- -202.52%
- Net Margin
- -206.94%
- ROE
- -78.75%
- ROIC
- -56.31%
- Revenue
- $16.38M · 61.10%
- Net Income
- $-43,315,210 · -63.57%
- EPS
- $-1.43 · -33.64%
- Op Income
- $-41,976,173
- FCF YoY
- -66.52%
- 52W High
- $8.95
- 52W Low
- $3.76
- 50D MA
- $6.79
- 200D MA
- $6.57
- Beta
- 0.53
- Avg Volume
- 72.87K
Get TickerSpark's AI analysis on PROF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 16, 25 | Menawat Arun Swarup | buy | 12,027 |
| May 15, 25 | Menawat Arun Swarup | buy | 10,003 |
| Dec 20, 12 | HOFER MICHAEL | sell | 40,000 |
| Dec 18, 12 | HOFER MICHAEL | buy | 40,000 |
| Jun 19, 12 | TEJADA FRED | buy | 500,000 |
| Jun 19, 12 | BLANCHET JUSTIN | buy | 500,000 |
| Jun 19, 12 | Schweitzer John H. | buy | 500,000 |
| Jun 19, 12 | HOFER MICHAEL | buy | 500,000 |
| Jun 1, 12 | HOFER MICHAEL | other | 0 |
| Jun 19, 12 | BLANCHET JUSTIN | other | 500,000 |
Our PROF coverage
Recent articles, reports, and earnings notes.
No research on PROF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PROF report →Similar companies
Peers in the same neighborhood.